Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Myeloablative conditioning using a dose escalation of clofarabine in combination
with cytarabine (ARA-C) and total body irradiation (TBI) will lead to improved survival for
previously untransplanted children and adolescents with acute lymphoblastic leukemia (ALL)
and acute non-lymphoblastic leukemia (ANLL)followed by allogeneic stem cell transplantation
(AlloSCT).